Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 42

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 42
---
 2021 as its independent compensation consultant to advise the Committee. At the Committee’s direction, WTW:

• Attends all regularly scheduled Committee meetings, including, when invited, executive sessions;

• Reviews the Company’s executive compensation strategy and programs to ensure appropriateness and market-competitiveness;

• Provides research, data analyses, pay benchmarking data for our comparator groups, survey information and design expertise in developing compensation programs and pay recommendations for executive officers;

• Regularly updates the Committee on market trends, changing practices and legislation pertaining to executive compensation and benefits;

• Facilitates and summarizes the CEO performance assessment conducted by the Board and provides information to facilitate compensation decisions for the CEO;

• Advises the Committee on the appropriate comparator groups for benchmarking compensation and benefits;

• Reviews the Company's compensation disclosure for the proxy statement, including pay versus performance; and

• Undertakes special projects at the request of the Committee or its chair.

Fees paid to WTW for executive compensation consulting services in 2024 totaled $212,847. In addition, our management purchased compensation surveys from WTW that management used to evaluate executive and non-executive jobs and

#### 2025 Proxy Statement45

#### Executive Compensation
retained WTW for health and benefits consulting services for an aggregate cost of $102,562 in 2024. Also, our management has retained WTW and its subsidiaries to provide non-executive compensation consulting services consisting of insurance brokering and marketing services for many years, and in 2024 we paid WTW and/or its subsidiaries non-executive compensation consulting fees and commissions totaling $177,542,598. These fees were related to the growth in sales of our insurance products through brokers, which were earned when customers of WTW and/or its subsidiaries chose our insurance products.

The representatives of WTW who provide executive compensation consulting services to the Committee have no involvement in the planning or delivery to the Company of any of the services unrelated to executive compensation and their work is covered under WTW's Conflicts of Interest Policy. As reported by WTW to the Committee, the total payments from the Company to WTW and/or its subsidiaries in 2024 represented less than 2% of WTW’s parent company’s annual revenue. Prior to engaging WTW, the Committee assessed, and on an annual basis thereafter, the Committee has reviewed, WTW’s independence pursuant to applicable SEC and NYSE rules and concluded that no conflict of interest exists with respect to the work WTW performs for the Committee.

#### Market